The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma
Abstract
BACKGROUND: Although controversial, some believe that preoperative chemoradiation increases the use of sphincter‐preserving surgery in low rectal carcinoma patients. This article investigates the relationship between objective tumor response and sphincter preservation in low rectal carcinoma patients. METHODS: The authors reviewed the records of 238 patients with T3 or T4 low rectal carcinoma (≤ 6 cm from the anal verge) who underwent preoperative pelvic chemoradiation (45 Gy/25 fractions/5 weeks, n = 182 or 52.5 Gy/30 fractions/5 weeks, n = 56 with continuous infusion 5‐fluorouracil at 300 mg/m 2, Monday to Friday) followed by mesorectal (n = 223) or local excision (n = 15). A logistic regression analysis was used to analyze the influence of objective tumor response (defined as complete clinical response) and other prognostic factors on sphincter preservation. Because degrees of partial response could not be objectively defined retrospectively, the influence of partial response on sphincter preservation could not be evaluated. RESULTS: Overall, 49% of patients (117 of 238) had sphincter‐preserving surgery. The clinical complete response rate was 47%. Independent predictors of sphincter preservation included the year of surgery, tumor distance from the anal verge, circumferential tumor involvement, and response to chemoradiation. The sphincter preservation rate increased over the period of the study (from 28% [December 1989 to December 1992] to 44% [January 1993 to December 1996] to 67% [January 1997 to December 2000]). The difference in the rates of sphincter preservation according to response was most striking among patients with tumors 3 cm or less from the anal verge (44% vs. 22%, P = 0.01). The pelvic disease recurrence rate among patients undergoing sphincter‐preserving surgery has been less than 10% since January 1993 and was not statistically different between the groups treated from January 1993 to December 1996 and from January 1997 to December 2000. CONCLUSIONS: There has been an increase in the use of sphincter‐preserving surgery without an increase in pelvic disease recurrence over the past decade. Although not necessary for sphincter preservation, clinical response to preoperative chemoradiation independently contributed to sphincter‐preserving surgery, particularly in patients with low rectal tumors. Cancer 2003;97:517–24. © 2003 American Cancer Society. DOI 10.1002/cncr.11075
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., & Gerard, J.-P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2396 · Cited by 815
Cited by
Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bębenek, M., Pudełko, M., Kryj, M., Olędzki, J., Szmeja, J., Słuszniak, J., et al. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2003.12.006 · Cited by 505
Neuroimmune mechanisms in postoperative ileus
Boeckxstaens, G. E., & de Jonge, W. J. (2009) · Gut · doi:10.1136/gut.2008.169250 · Cited by 356
Garcia-Aguilar, J., Shi, Q., Thomas, C. R., Chan, E., Cataldo, P., Marcet, J., Medich, D., Pigazzi, A., Oommen, S., & Posner, M. C. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1933-7 · Cited by 304
Metadata
- Authors
- Crane, C. H., Skibber, J. M., Feig, B. W., Vauthey, J., Thames, H. D., Curley, S. A., Rodriguez‐Bigas, M. A., Wolff, R. A., Ellis, L. M., Delclos, M. E., Lin, E. H., & Janjan, N. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-01-03
- Volume
- 97
- Issue
- 2
- Pages
- 517-524
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2028945958
- Cited by
- 181
- References
- 2
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.